LOW-VOLUME · FEMALE-LED
cromolyn Side Effects
cromolyn (also sold as Intal) is a LOW-VOLUME FAERS extract #417 of 524 by FAERS report count. Still opens on FEMALE-LED: 73% of sex-coded reports are female (2,265 F / 859 M).
Data updated 2026-05-15
- 3,396
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
cromolyn reporting skew - 73% of sex-coded reports are female (2,265 F / 859 M). Volume band LOW-VOLUME #417 of 524 by FAERS report count; caseload SIGNAL.
Thinner FAERS extract for cromolyn (Intal) (3,396 reports #417 of 524 by FAERS report count). 73% of sex-coded reports are female (2,265 F / 859 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-MARKED · HOSP-MID · FEMALE-LED.
TREATMENT FAILURE leads 1,004 of 3,396 reports
FEMALE-LED reporters · age peak 45-64
Female-led reporters (73% of sex-coded rows)
Age peak 45-64 (514 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 47 reports (1.4% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| DEATH | 20 |
| RESPIRATORY FAILURE | 4 |
| CARDIAC ARREST | 3 |
| PNEUMONIA | 3 |
| PULMONARY EMBOLISM | 3 |
| SEPSIS | 3 |
| SEPTIC SHOCK | 3 |
| CEREBROVASCULAR ACCIDENT | 2 |
| CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2 |
| COMPRESSION FRACTURE | 2 |
| DIARRHOEA | 2 |
| DYSPNOEA | 2 |
| ERYTHEMA | 2 |
| FALL | 2 |
| LEUKOCYTOSIS | 2 |
| NAUSEA | 2 |
| OBESITY | 2 |
| OEDEMA | 2 |
| RASH ERYTHEMATOUS | 2 |
| RESPIRATORY DISTRESS | 2 |
Reactions in Hospitalization Reports
Hospitalization mid-share (408, 12.0%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| NAUSEA | 53 |
| FATIGUE | 46 |
| DIARRHOEA | 43 |
| HEADACHE | 42 |
| URTICARIA | 41 |
| DYSPNOEA | 40 |
| ANAPHYLACTIC REACTION | 37 |
| DIZZINESS | 37 |
| VOMITING | 34 |
| ASTHMA | 32 |
| PAIN | 32 |
| HYPERSENSITIVITY | 31 |
| PYREXIA | 31 |
| FALL | 29 |
| BACK PAIN | 26 |
| CHEST PAIN | 26 |
| COUGH | 26 |
| MIGRAINE | 26 |
How to read cromolyn FAERS figures (SIGNAL · DEATH-MARKED · HOSP-MID)
FAERS holds 3,396 voluntary reports linked to cromolyn (Intal), 2004-2025. Death is listed on 47 (1.4%). Hospitalization appears on 408 (12.0%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and FEMALE-LED skew still differ by drug; not a complete safety profile.
Read with cromolyn
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 3,393 FAERS cases (Δ 3 lighter vs cromolyn); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 3,350 FAERS cases (Δ 46 lighter vs cromolyn); DEATH-MARKED · HOSP-MID · MALE-LED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 3,344 FAERS cases (Δ 52 lighter vs cromolyn); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 3,330 FAERS cases (Δ 66 lighter vs cromolyn); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 60.7 pp vs cromolyn's DEATH-MARKED): CASELOAD · HOSP-MID.
cromolyn stamps SIGNAL · FEMALE-LED; class peers and methodology beat restating the same FAERS caveats on every effects URL.